Time for reflection and implementation
Kirit S Javali, Partner, Jafa & Javali highlights the need for policies to address concerns, while ensuring affordability and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Regulations must be implementable, practical
Dr Sauren Das, Executive Director, Excel Life Sciences suggests that while framing regulations, regulators should handpick the bad…
Urgently require systematic investment in infrastructure enhancements
The Government of India is in a perfect position to provide direction and support to meet the urgent unmet needs of the 70+…
Strategies for making high pharma quality affordable
Ajaz S Hussain, Former Deputy Director Office of Pharmaceutical Science at the US FDA and currently the Founder of Insight, Advice…
Ethical behaviour will drive success
Ranjit Shahani, Vice Chairman and Managing Director, Novartis India elucidates about India’s pharmaceutical sector, which is going…
Strategies to stay ahead in the race
Rajiv Malik, President, Mylan outlines the strategies that Indian pharmaceutical firms should implement to ensure growth in the…
The right mix for success
Pawan Chaudhary, Chairman and Managing Director, Venus Remedies opines that a multi-pronged strategic approach is essential to…
‘Leadership plays a key role in driving the company to success’
Dr Ajit Dangi, President and Chief Executive Officer, Dansssen Consulting talks about some critical strategic drivers to survive…
’Growth is impressive, generic opportunity is shrinking’
Utkarsh Palnitkar, Partner and National Head Pharma & Life Sciences, KPMG in India, aims to capture the opportunities…
Success strategies for pharma firms
Satish Khanna, Director, Valmax Corporate Services and Ex Group President of Lupin India, elaborates on the various approaches…
Clinical trial reforms – two steps forward, one step back
Dr Chandrashekhar Potkar, Editor, Perspectives in Clinical Research, Indian Society for Clinical Research, examines the…
India needs to adopt bold strategies
As MNCs ‘stretch out’ leading Indian pharma companies through protracted litigations, Gopakumar G Nair, Founder and Karthika Nair,…
Navigating the Indian legal maze: Challenges
Dr Milind Antani, Head, Pharma and Life Sciences and Anay Shukla, Member, Pharma and Life Science team, Nishith Desai Associates…
Positioning for success: Protecting market share with sustainable compliance
Bob Rhoades, Vice President, Quality and Compliance Consulting, Quintiles gives an insight about the essentiallity of the…
Critical success factors for the medical device industry
The under-penetration of medical devices in India provides a compelling opportunity for medical device manufacturers to increase…
Migration to a disruptive innovation model
Trapped within the mental constructs of the nominal innovation model, the pharmaceutical industry is not able to harness the tools…
Bigger is not better Sample preparation in pharma industry
PRVS Varma, Country Manager, Retsch India speaks on the trend to have small samples with controlled particle size and how…
Clinical trials in India: The churn continues
Usha Sharma reports on the implications of two recent notifications which have once again stirred up the clinical trials industry…
Effect of BITs on patents
Manoj K Singh, Founding Partner, Singh & Associates, speaks about the effect of Bilateral Investment Treaties (BITs) on the…
Regulatory transparency and integration key driver of future healthcare industry
Industry experts forecast that regulatory transparency and integration along with ADCs and multi use facilities will be key…